Mass spectrometry assay for eIF4E and eIF4E regulon activity

Details for Australian Patent Application No. 2008323933 (hide)

Owner Translational Therapeutics, Inc.

Inventors Jamieson Jr., Gordon A.

Agent Allens Arthur Robinson

Pub. Number AU-A-2008323933

PCT Pub. Number WO2009/061904

Priority 60/985,787 06.11.07 US

Filing date 6 November 2008

Wipo publication date 14 May 2009

International Classifications

G01N 5/00 (2006.01) Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/061904 Priority application(s): WO2009/061904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323934-Methods of measuring cell viability without using control cells

2008323932-Systems and methods for workflow automation, adaptation and integration